Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB26FSU90
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,829
Award facts
- Contract value 100% obligated
- $20,829.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $20,829.30 to DMS Pharmaceutical Group Inc. for Nexplanon 68 mg implants, a subdermal contraceptive device. The contract, issued on October 29, 2025, with an ultimate completion date of November 20, 2025, contains no set-aside designation and represents a competitive procurement under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the agency. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected based on its established capability to supply specialized pharmaceutical and medical products to Department of Defense healthcare facilities.
This delivery order falls under DMS Pharmaceutical Group's participation in the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a comprehensive $30.3 billion acquisition strategy that establishes multiple regional prime vendor contractors. The underlying IDC, awarded to DMS Pharmaceutical Group on November 13, 2025, carries a $499.999 billion ceiling value with a completion date of December 31, 2036, and authorizes the issuance of firm fixed-price delivery orders for branded and generic pharmaceuticals, biologics, and medical consumables to support military healthcare operations worldwide. The company's demonstrated performance across diverse product lines and therapeutic categories positions it as a critical supplier within the federal military medical supply chain.
Quick answers
Who was awarded contract SPE2DB26FSU90?
SPE2DB26FSU90 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 29, 2025.
How much is contract SPE2DB26FSU90 worth?
The government has obligated $20,829 on SPE2DB26FSU90.
Is contract SPE2DB26FSU90 an order under another contract?
Yes. SPE2DB26FSU90 is a delivery order under SPE2DB22D9367, an indefinite delivery contract.
Was contract SPE2DB26FSU90 competed?
The extent of competition for SPE2DB26FSU90 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award